Evidence map›Paper›PMID 39075722›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Dissecting the Impact of Maternal Androgen Exposure on Developmental Programming through Targeting the Androgen Receptor.

Haojiang Lu, Hong Jiang, Congru Li, Emilie Derisoud, Allan Zhao, Gustaw Eriksson, Eva Lindgren, Han-Pin Pui, Sanjiv Risal, Yu Pei and 6 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Haojiang LuDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, 17177, Sweden.ORCID 0000-0001-9051-0140
Hong JiangDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, 17177, Sweden.ORCID 0000-0002-8106-457X
Congru LiDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, 17177, Sweden.ORCID 0000-0001-7023-5962
Emilie DerisoudDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, 17177, Sweden.ORCID 0000-0001-5027-6214
Allan ZhaoDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, 17177, Sweden.ORCID 0000-0002-2492-0923
Gustaw ErikssonDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, 17177, Sweden.
Eva LindgrenDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, 17177, Sweden.
Han-Pin PuiDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, 17177, Sweden.
Sanjiv RisalDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, 17177, Sweden.ORCID 0000-0003-1723-5431
Yu PeiDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, 17177, Sweden.ORCID 0000-0002-6219-3587
Theresa MaxianDepartment of Obstetrics and Gynaecology, Reproductive Biology Unit, Placental Development Group, Medical University of Vienna, Vienna, 1090, Austria.
Claes OhlssonCentre for Bone and Arthritis Research, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, 40530, Sweden.ORCID 0000-0002-9633-2805
Anna BenrickDepartment of Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, 40530, Sweden.ORCID 0000-0003-4616-6789
Sandra HaiderDepartment of Obstetrics and Gynaecology, Reproductive Biology Unit, Placental Development Group, Medical University of Vienna, Vienna, 1090, Austria.ORCID 0000-0002-3612-7332
Elisabet Stener-VictorinDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, 17177, Sweden.ORCID 0000-0002-3424-1502
Qiaolin DengDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, 17177, Sweden.ORCID 0000-0001-5934-7816

Funding

Diabetes Foundation DIA2021-633Diabetes Foundation DIA2022-708Karolinska Institutet central faculty funding 20 190 079Karolinska Institutet KID 2020-00990Karolinska Institutet KID 2023-0005Knut and Alice Wallenberg Foundation 2019.0211Novo Nordisk Foundation NNF18OC0033992Novo Nordisk Foundation NNF19OC0056647Novo Nordisk Foundation NNF22OC0072904Regional Agreement on Medical Training and Clinical ResearchStockholm County CouncilSwedish Medical Research Council 2020-00253Swedish Medical Research Council 2022-00550
6 · The paper itself

Abstract

Women with polycystic ovary syndrome (PCOS) exhibit sustained elevation in circulating androgens during pregnancy, an independent risk factor linked to pregnancy complications and adverse outcomes in offspring. Yet, further studies are required to understand the effects of elevated androgens on cell type-specific placental dysfunction and fetal development. Therefore, a PCOS-like mouse model induced by continuous androgen exposure is examined. The PCOS-mice exhibited impaired placental and embryonic development, resulting in mid-gestation lethality. Co-treatment with the androgen receptor blocker, flutamide, prevents these phenotypes including germ cell specification. Comprehensive profiling of the placenta by whole-genome bisulfite and RNA sequencing shows a reduced proportion of trophoblast precursors, possibly due to the downregulation of Cdx2 expression. Reduced expression of Gcm1, Synb, and Prl3b1 is associated with reduced syncytiotrophoblasts and sinusoidal trophoblast giant cells, impairs placental labyrinth formation. Importantly, human trophoblast organoids exposed to androgens exhibit analogous changes, showing impaired trophoblast differentiation as a key feature in PCOS-related pregnancy complications. These findings provide new insights into the potential cellular targets for future treatments.

Indexed as

AndrogensDisease Models, AnimalPolycystic Ovary SyndromeReceptors, AndrogenAnimalsEmbryonic DevelopmentFemaleHumansMaternal ExposureMicePlacentaPregnancyAndrogensReceptors, Androgendevelopmental programminghuman trophoblast organoidsplacental developmentpolycystic ovary syndrome

Identifiers

PMID39075722
PMCPMC11423211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.